Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy

Lucile Capuron; Alain Ravaud; P.J. Neveu; Andrew H. Miller; Michael Maes; Robert Dantzer

doi:10.1038/sj.mp.4000995

Related publications

Article2001

Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy

Lucile Capuron, Alain Ravaud, N. Gualde, Eugène Bosmans, Robert Dantzer, Michael Maes, Pierre J. Neveu

Article2001

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

Michael Maes, Lucile Capuron, Alain Ravaud, Norbert Gualde, Eugene Bosmans, Belinda Egyed, Robert Dantzer, Pierre J. Neveu

Article2020

Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients

Theresa H. Wirtz, Lukas Buendgens, Ralf Weiskirchen, Sven H. Loosen, Nina Haehnsen, Tobias Puengel, Samira Abu Jhaisha, Jonathan F. Brozat, Philipp Hohlstein, Ger H. Koek, Albrecht Eisert, Raphael Mohr, Christoph Roderburg, Tom Luedde, Christian Trautwein, Frank Tacke, Alexander Koch

Article1995

Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity

Michael Maes, Annick Wauters, Hugo Neels, Simon Scharpé, An Van Gastel, Peter D'Hondt, D. Peeters, Paul Cosyns, Roger Desnyder

Article2019

P1573Chemotherapy-induced vasotoxicity in patients undergoing therapy for breast cancer

M Anastasiou, A S Antonopoulos, Evangelos Oikonomou, Flora Zagouri, Gerasimos Siasos, Georgia Vogiatzi, Sotiris Tsalamandris, C V Mistakidi, Θεοδώρα Ψαλτοπούλου, Aristotle Bamias, Meletios A Dimopoulos, Dimitris Tousoulis